MONDELEZ INTERNATIONAL INC-A (MDLZ) Fundamental Analysis & Valuation

NASDAQ:MDLZUS6092071058

Current stock price

57.075 USD
+0.87 (+1.54%)
Last:

This MDLZ fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. MDLZ Profitability Analysis

1.1 Basic Checks

  • MDLZ had positive earnings in the past year.
  • In the past year MDLZ had a positive cash flow from operations.
  • In the past 5 years MDLZ has always been profitable.
  • MDLZ had a positive operating cash flow in each of the past 5 years.
MDLZ Yearly Net Income VS EBIT VS OCF VS FCFMDLZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

1.2 Ratios

  • MDLZ has a Return On Assets of 3.43%. This is in the better half of the industry: MDLZ outperforms 66.67% of its industry peers.
  • MDLZ's Return On Equity of 9.49% is fine compared to the rest of the industry. MDLZ outperforms 72.41% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 5.26%, MDLZ is in the better half of the industry, outperforming 62.07% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for MDLZ is in line with the industry average of 7.14%.
Industry RankSector Rank
ROA 3.43%
ROE 9.49%
ROIC 5.26%
ROA(3y)5.7%
ROA(5y)5.47%
ROE(3y)14.7%
ROE(5y)13.89%
ROIC(3y)7.9%
ROIC(5y)7.13%
MDLZ Yearly ROA, ROE, ROICMDLZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15

1.3 Margins

  • MDLZ's Profit Margin of 6.36% is amongst the best of the industry. MDLZ outperforms 81.61% of its industry peers.
  • In the last couple of years the Profit Margin of MDLZ has declined.
  • MDLZ's Operating Margin of 9.48% is fine compared to the rest of the industry. MDLZ outperforms 75.86% of its industry peers.
  • In the last couple of years the Operating Margin of MDLZ has declined.
  • MDLZ has a Gross Margin of 28.38%. This is in the better half of the industry: MDLZ outperforms 66.67% of its industry peers.
  • In the last couple of years the Gross Margin of MDLZ has declined.
Industry RankSector Rank
OM 9.48%
PM (TTM) 6.36%
GM 28.38%
OM growth 3Y-8.01%
OM growth 5Y-9.55%
PM growth 3Y-9.66%
PM growth 5Y-13.81%
GM growth 3Y-7.55%
GM growth 5Y-6.31%
MDLZ Yearly Profit, Operating, Gross MarginsMDLZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10 20 30

3

2. MDLZ Health Analysis

2.1 Basic Checks

  • MDLZ has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
  • MDLZ has less shares outstanding than it did 1 year ago.
  • MDLZ has less shares outstanding than it did 5 years ago.
  • MDLZ has a worse debt/assets ratio than last year.
MDLZ Yearly Shares OutstandingMDLZ Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
MDLZ Yearly Total Debt VS Total AssetsMDLZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20B 40B 60B

2.2 Solvency

  • An Altman-Z score of 2.22 indicates that MDLZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.22, MDLZ is in line with its industry, outperforming 57.47% of the companies in the same industry.
  • The Debt to FCF ratio of MDLZ is 6.55, which is on the high side as it means it would take MDLZ, 6.55 years of fcf income to pay off all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 6.55, MDLZ is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • A Debt/Equity ratio of 0.77 indicates that MDLZ is somewhat dependend on debt financing.
  • MDLZ has a Debt to Equity ratio (0.77) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 6.55
Altman-Z 2.22
ROIC/WACC0.69
WACC7.58%
MDLZ Yearly LT Debt VS Equity VS FCFMDLZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B 25B

2.3 Liquidity

  • A Current Ratio of 0.59 indicates that MDLZ may have some problems paying its short term obligations.
  • MDLZ has a worse Current ratio (0.59) than 85.06% of its industry peers.
  • MDLZ has a Quick Ratio of 0.59. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
  • MDLZ's Quick ratio of 0.39 is on the low side compared to the rest of the industry. MDLZ is outperformed by 81.61% of its industry peers.
Industry RankSector Rank
Current Ratio 0.59
Quick Ratio 0.39
MDLZ Yearly Current Assets VS Current LiabilitesMDLZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B 20B

4

3. MDLZ Growth Analysis

3.1 Past

  • MDLZ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -15.36%.
  • The Earnings Per Share has been growing slightly by 2.19% on average over the past years.
  • MDLZ shows a small growth in Revenue. In the last year, the Revenue has grown by 5.75%.
  • The Revenue has been growing slightly by 7.71% on average over the past years.
EPS 1Y (TTM)-15.36%
EPS 3Y-0.68%
EPS 5Y2.19%
EPS Q2Q%10.77%
Revenue 1Y (TTM)5.75%
Revenue growth 3Y6.96%
Revenue growth 5Y7.71%
Sales Q2Q%9.29%

3.2 Future

  • Based on estimates for the next years, MDLZ will show a quite strong growth in Earnings Per Share. The EPS will grow by 8.76% on average per year.
  • The Revenue is expected to grow by 3.25% on average over the next years.
EPS Next Y6.12%
EPS Next 2Y8.63%
EPS Next 3Y8.1%
EPS Next 5Y8.76%
Revenue Next Year3.48%
Revenue Next 2Y3.34%
Revenue Next 3Y3.31%
Revenue Next 5Y3.25%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
MDLZ Yearly Revenue VS EstimatesMDLZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 10B 20B 30B 40B 50B
MDLZ Yearly EPS VS EstimatesMDLZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2 4 6

3

4. MDLZ Valuation Analysis

4.1 Price/Earnings Ratio

  • MDLZ is valuated rather expensively with a Price/Earnings ratio of 19.55.
  • Compared to the rest of the industry, the Price/Earnings ratio of MDLZ is on the same level as its industry peers.
  • Compared to an average S&P500 Price/Earnings ratio of 25.23, MDLZ is valued a bit cheaper.
  • MDLZ is valuated rather expensively with a Price/Forward Earnings ratio of 18.42.
  • MDLZ's Price/Forward Earnings ratio is in line with the industry average.
  • When comparing the Price/Forward Earnings ratio of MDLZ to the average of the S&P500 Index (22.42), we can say MDLZ is valued inline with the index average.
Industry RankSector Rank
PE 19.55
Fwd PE 18.42
MDLZ Price Earnings VS Forward Price EarningsMDLZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • MDLZ's Enterprise Value to EBITDA ratio is in line with the industry average.
  • MDLZ's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 22.62
EV/EBITDA 17.65
MDLZ Per share dataMDLZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 -10 20 30

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates MDLZ does not grow enough to justify the current Price/Earnings ratio.
  • MDLZ has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.19
PEG (5Y)8.92
EPS Next 2Y8.63%
EPS Next 3Y8.1%

6

5. MDLZ Dividend Analysis

5.1 Amount

  • MDLZ has a Yearly Dividend Yield of 3.54%.
  • MDLZ's Dividend Yield is a higher than the industry average which is at 2.47.
  • MDLZ's Dividend Yield is rather good when compared to the S&P500 average which is at 1.89.
Industry RankSector Rank
Dividend Yield 3.54%

5.2 History

  • On average, the dividend of MDLZ grows each year by 10.23%, which is quite nice.
  • MDLZ has been paying a dividend for at least 10 years, so it has a reliable track record.
  • MDLZ has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)10.23%
Div Incr Years11
Div Non Decr Years11
MDLZ Yearly Dividends per shareMDLZ Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5

5.3 Sustainability

  • 101.47% of the earnings are spent on dividend by MDLZ. This is not a sustainable payout ratio.
  • MDLZ's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP101.47%
EPS Next 2Y8.63%
EPS Next 3Y8.1%
MDLZ Yearly Income VS Free CF VS DividendMDLZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B
MDLZ Dividend Payout.MDLZ Dividend Payout, showing the Payout Ratio.MDLZ Dividend Payout.PayoutRetained Earnings

MDLZ Fundamentals: All Metrics, Ratios and Statistics

MONDELEZ INTERNATIONAL INC-A

NASDAQ:MDLZ (3/23/2026, 2:20:08 PM)

57.075

+0.87 (+1.54%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)02-03
Earnings (Next)04-27
Inst Owners88.72%
Inst Owner Change-0.62%
Ins Owners0.18%
Ins Owner Change5.05%
Market Cap73.16B
Revenue(TTM)38.54B
Net Income(TTM)2.45B
Analysts77.65
Price Target67.99 (19.12%)
Short Float %2.62%
Short Ratio3.01
Dividend
Industry RankSector Rank
Dividend Yield 3.54%
Yearly Dividend1.91
Dividend Growth(5Y)10.23%
DP101.47%
Div Incr Years11
Div Non Decr Years11
Ex-Date03-31
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)0.76%
Min EPS beat(2)0.24%
Max EPS beat(2)1.28%
EPS beat(4)4
Avg EPS beat(4)4.31%
Min EPS beat(4)0.24%
Max EPS beat(4)10.18%
EPS beat(8)7
Avg EPS beat(8)5.06%
EPS beat(12)11
Avg EPS beat(12)5.53%
EPS beat(16)15
Avg EPS beat(16)5.46%
Revenue beat(2)0
Avg Revenue beat(2)-0.89%
Min Revenue beat(2)-1.64%
Max Revenue beat(2)-0.15%
Revenue beat(4)0
Avg Revenue beat(4)-1.07%
Min Revenue beat(4)-2.09%
Max Revenue beat(4)-0.15%
Revenue beat(8)0
Avg Revenue beat(8)-1.43%
Revenue beat(12)3
Avg Revenue beat(12)-0.47%
Revenue beat(16)7
Avg Revenue beat(16)0.45%
PT rev (1m)-0.22%
PT rev (3m)-2.24%
EPS NQ rev (1m)-2.44%
EPS NQ rev (3m)-23.23%
EPS NY rev (1m)-3.08%
EPS NY rev (3m)-3.38%
Revenue NQ rev (1m)-0.36%
Revenue NQ rev (3m)-1.9%
Revenue NY rev (1m)-0.21%
Revenue NY rev (3m)-0.45%
Valuation
Industry RankSector Rank
PE 19.55
Fwd PE 18.42
P/S 1.9
P/FCF 22.62
P/OCF 16.21
P/B 2.83
P/tB N/A
EV/EBITDA 17.65
EPS(TTM)2.92
EY5.12%
EPS(NY)3.1
Fwd EY5.43%
FCF(TTM)2.52
FCFY4.42%
OCF(TTM)3.52
OCFY6.17%
SpS30.06
BVpS20.16
TBVpS-14.14
PEG (NY)3.19
PEG (5Y)8.92
Graham Number36.39
Profitability
Industry RankSector Rank
ROA 3.43%
ROE 9.49%
ROCE 7.36%
ROIC 5.26%
ROICexc 5.48%
ROICexgc 44.22%
OM 9.48%
PM (TTM) 6.36%
GM 28.38%
FCFM 8.39%
ROA(3y)5.7%
ROA(5y)5.47%
ROE(3y)14.7%
ROE(5y)13.89%
ROIC(3y)7.9%
ROIC(5y)7.13%
ROICexc(3y)8.16%
ROICexc(5y)7.43%
ROICexgc(3y)63.45%
ROICexgc(5y)50.76%
ROCE(3y)10.65%
ROCE(5y)9.63%
ROICexgc growth 3Y21.26%
ROICexgc growth 5Y4.14%
ROICexc growth 3Y1.32%
ROICexc growth 5Y-3.02%
OM growth 3Y-8.01%
OM growth 5Y-9.55%
PM growth 3Y-9.66%
PM growth 5Y-13.81%
GM growth 3Y-7.55%
GM growth 5Y-6.31%
F-Score5
Asset Turnover0.54
Health
Industry RankSector Rank
Debt/Equity 0.77
Debt/FCF 6.55
Debt/EBITDA 3.97
Cap/Depr 94.18%
Cap/Sales 3.32%
Interest Coverage 6.41
Cash Conversion 90.06%
Profit Quality 131.99%
Current Ratio 0.59
Quick Ratio 0.39
Altman-Z 2.22
F-Score5
WACC7.58%
ROIC/WACC0.69
Cap/Depr(3y)97.41%
Cap/Depr(5y)92.16%
Cap/Sales(3y)3.4%
Cap/Sales(5y)3.29%
Profit Quality(3y)93.68%
Profit Quality(5y)93.08%
High Growth Momentum
Growth
EPS 1Y (TTM)-15.36%
EPS 3Y-0.68%
EPS 5Y2.19%
EPS Q2Q%10.77%
EPS Next Y6.12%
EPS Next 2Y8.63%
EPS Next 3Y8.1%
EPS Next 5Y8.76%
Revenue 1Y (TTM)5.75%
Revenue growth 3Y6.96%
Revenue growth 5Y7.71%
Sales Q2Q%9.29%
Revenue Next Year3.48%
Revenue Next 2Y3.34%
Revenue Next 3Y3.31%
Revenue Next 5Y3.25%
EBIT growth 1Y-45.43%
EBIT growth 3Y-1.61%
EBIT growth 5Y-2.57%
EBIT Next Year34.33%
EBIT Next 3Y15.04%
EBIT Next 5Y13.29%
FCF growth 1Y-8.17%
FCF growth 3Y2.52%
FCF growth 5Y0.85%
OCF growth 1Y-8.07%
OCF growth 3Y4.92%
OCF growth 5Y2.63%

MONDELEZ INTERNATIONAL INC-A / MDLZ Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for MONDELEZ INTERNATIONAL INC-A?

ChartMill assigns a fundamental rating of 4 / 10 to MDLZ.


Can you provide the valuation status for MONDELEZ INTERNATIONAL INC-A?

ChartMill assigns a valuation rating of 3 / 10 to MONDELEZ INTERNATIONAL INC-A (MDLZ). This can be considered as Overvalued.


What is the profitability of MDLZ stock?

MONDELEZ INTERNATIONAL INC-A (MDLZ) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for MDLZ stock?

The Price/Earnings (PE) ratio for MONDELEZ INTERNATIONAL INC-A (MDLZ) is 19.55 and the Price/Book (PB) ratio is 2.83.


Can you provide the dividend sustainability for MDLZ stock?

The dividend rating of MONDELEZ INTERNATIONAL INC-A (MDLZ) is 6 / 10 and the dividend payout ratio is 101.47%.